dr. mirza on the evolving treatment landscape in recurrent ovarian cancer
Published 4 years ago • 173 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
2:18
dr. mirza on efficacy of niraparib/bevacizumab combo in recurrent ovarian cancer
-
2:11
dr. mirza on the rationale for the avanova trial in recurrent ovarian cancer
-
0:52
dr. mirza on safety profile of niraparib/bevacizumab in recurrent ovarian cancer
-
2:18
dr. mirza on final data of the nsgo-avanova2/engot-ov24 trial in ovarian cancer
-
1:35
dr. mirza on the phase iii nova trial in ovarian cancer
-
1:30
dr. mirza on niraparib efficacy across ovarian cancer subgroups
-
0:49
dr. mirza on the engot-ov42-nsgo/avanova-triplet trial in recurrent ovarian cancer
-
0:53
dr. mirza on the impact of parp inhibitors in ovarian cancer
-
1:13:10
the state of ovarian cancer: exploring the landscape of systemic therapy
-
0:57
dr. mirza on impact of niraparib in ovarian cancer
-
2:42
an overview of the ovarian cancer treatment landscape
-
1:41
dr. mirza on niraparib plus bevacizumab combo in ovarian cancer
-
0:56
dr. mirza on the implications of the nsgo-avanova2/engot-ov24 trial in ovarian cancer
-
2:26
dr. mirza discusses niraparib dose modifications for ovarian cancer patients with low body weight
-
8:29
esmo 2019: dr. mirza on important trials with parp inhibitors in ovarian cancer
-
34:43
treatments for recurrent ovarian cancer
-
7:10
jonathan a ledermann – maintenance treatment for recurrent ovarian carcinoma
-
1:34
dr. birrer discusses recurrent ovarian cancer treatment
-
1:24
dr. ledermann on response to rucaparib in recurrent ovarian cancer